Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.

Pfizer chief corporate affairs officer Sally Susman is departing the company after roughly two decades, CEO Albert Bourla ...

NEW YORK - Sally Susman, Pfizer's executive VP and chief corporate affairs officer, will depart the pharmaceutical giant at ...

Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, provides insights from her newly released book, Breaking Through, to help leaders based on her expertise and ...

Pfizer's chief corporate affairs officer, Sally Susman, recounts how the company managed the massive communications challenge that came with Covid-19 and the race to produce an effective vaccine ...

Susman described the moment when Pfizer’s top brass, huddled in a small Connecticut office, learned the vaccine worked. “We had over 44,000 people in our clinical trials,” she said.

Susman says that The Business Roundtable’s new definition of a company – that shareholder value no longer trumps all other stakeholders — helps make the case for young people to consider a ...